Stock Events

Stock Events

Bellevue Group

€7.46

28

+€0.06+0.81% Friday 19:46

Statistics

Day High

7.6

Day Low

7.46

52W High

7.6

52W Low

7.46

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

2.19%

Dividend

0.16

Upcoming

Dividend Payment

Dividend Payment

Dividends

2.19%Dividend Yield

Mar 26

€0.16

Mar 25

€0.73

Mar 24

€1.17

Mar 23

€2.02

Mar 22

€2.63

10Y Growth

-15.81%

5Y Growth

-34.49%

3Y Growth

-56.74%

1Y Growth

-77.7%

Earnings

23JulExpected

Q4 2025

Q2 2026

999

333

-333

-999

Expected EPS

N/A

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SJZN.STU. It's not an investment recommendation.

Zurich Insurance Group

Verizon Communications

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Novartis is a global healthcare company that competes with Bellevue in the pharmaceutical and healthcare investment sectors.

Roche Holding AG is a major player in the pharmaceuticals and diagnostics market, directly competing with Bellevue's investments in healthcare.

Pfizer is a leading pharmaceutical company, competing with Bellevue in the healthcare and pharmaceutical investment space.

Merck & Co., Inc. is a global healthcare company that competes with Bellevue through its pharmaceutical products and healthcare solutions.

Johnson & Johnson

Johnson & Johnson is a comprehensive healthcare firm that competes across various segments, including pharmaceuticals, medical devices, and consumer health products.

AbbVie is a biopharmaceutical company that competes with Bellevue in the healthcare investment sector, particularly in pharmaceuticals.

Amgen is a biotechnology firm competing with Bellevue in the biopharmaceutical investment space.

GlaxoSmithKline is a global healthcare company, competing with Bellevue in pharmaceuticals and healthcare products.

Bristol-Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company, competing with Bellevue in the development and commercialization of pharmaceuticals.

Sanofi is a global biopharmaceutical company competing with Bellevue in the healthcare and pharmaceutical sectors.

About

Bellevue Group AG is an asset management firm providing financial services across Switzerland, the United Kingdom, Germany, and various international markets. The company offers a diverse range of investment products, emphasizing specialized healthcare equity, distinct niche sectors, and entrepreneurial strategies. Additionally, they manage various investment funds and deliver tailored financial solutions to institutional, intermediary, and individual clients, alongside offering investment advisory and research services. Established in 1993, its headquarters are situated in Küsnacht, Switzerland.

Show more...

CEO

Markus Peter

Employees

85

Country

Switzerland

ISIN

CH0028422100

WKN

000A0LG3Z

Listings

0 Comments

Share your thoughts

FAQ

What is Bellevue Group stock price today?▼

The current price of SJZN.STU is €7.46 EUR — it has increased by +0.81% in the past 24 hours. Watch Bellevue Group stock price performance more closely on the chart.

What is Bellevue Group stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Bellevue Group stocks are traded under the ticker SJZN.STU.

Does Bellevue Group pay dividends?▼

Yes, SJZN.STU dividends are paid annual. The last dividend per share was 0.16 EUR. As of today, Dividend Yield (FWD)% is 2.19%.

How many employees does Bellevue Group have?▼

As of September 06, 2026, the company has 85 employees.

In which sector is Bellevue Group located?▼

Bellevue Group operates in the Finance & Payments sector.

When did Bellevue Group complete a stock split?▼

Bellevue Group has not had any recent stock splits.

Where is Bellevue Group headquartered?▼

Bellevue Group is headquartered in Zurich, Switzerland.